Orthocell Limited (OCC) 2022年年度报告「ASX」.pdf

1、Appendix 4E Preliminary final Report +See chapter 19 for defined terms 30/06/2016 Appendix 4E Page 1 Rules 4.3A Appendix 4E Preliminary final report Name of entity ORTHOCELL LIMITED ABN or equivalent company reference Financial year ended(current period)57 118 897 135 30 June 2022 For announcement t

2、o the market Current year reported amount$Change up/(down)from previous year%Revenues from product sales 1,474,946 up 44.9%Other revenues from continuing operations 330,839 up 39.1%Total revenues from continuing operations 1,805,785 up 43.8%Loss from ordinary activities after tax attributable to mem

3、bers 9,106,585 up 0.8%Net loss for the period attributable to members 9,106,585 up 0.8%Dividends(distributions)Amount per security Franked amount per security Interim dividend Nil-Final dividend Nil-Previous corresponding period Nil-+Record date for determining entitlements to the dividend,(in the c

4、ase of a trust,distribution)N/A Net Tangible Assets per share 30 June 2022 30 June 2021 Net tangible asset backing per ordinary security (cents per share)4.40 8.16 The above results should be read in conjunction with the notes and commentary contained in this report.For personal use onlyAppendix 4E

5、Preliminary final Report +See chapter 19 for defined terms 30/06/2016 Appendix 4E Page 2 Compliance statement 1 This report has been prepared in accordance with AASB Standards,other AASB authoritative pronouncements and Urgent Issues Group Consensus Views or other standards acceptable to ASX.2 This

6、report,and the+accounts upon which the report is based(if separate),use the same accounting policies.3 This report does give a true and fair view of the matters disclosed.4 This report is based on+accounts to which one of the following applies.(Tick one)The+accounts have been audited.The+accounts ha